Detalhe da pesquisa
1.
The development and evaluation of dose-prediction tools for allopurinol therapy (Easy-Allo tools).
Br J Clin Pharmacol
; 90(5): 1268-1279, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38359899
2.
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial.
Ann Rheum Dis
; 82(12): 1626-1634, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37652661
3.
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.
Ann Rheum Dis
; 82(10): 1248-1257, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37495237
4.
Predicting gout flares in people starting allopurinol using the start-low go-slow dose escalation strategy.
Arthritis Care Res (Hoboken)
; 2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38766703
5.
Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand - A retrospective cohort study.
Semin Arthritis Rheum
; 64: 152359, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38157761
6.
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.
Arthritis Rheumatol
; 75(10): 1703-1713, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37494275
7.
Long-Term Follow-up of a Randomized Controlled Trial of Allopurinol Dose Escalation to Achieve Target Serum Urate in People With Gout.
J Rheumatol
; 49(12): 1372-1378, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35777814
8.
Rates of Joint Replacement Surgery in New Zealand, 1999-2015: A Comparison of Rheumatoid Arthritis and Osteoarthritis.
J Rheumatol
; 44(12): 1823-1827, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29032353